Case report: immunotherapy response in pancreatic cancer after MSI-H emerged post-chemotherapy
{{output}}
Background: Microsatellite instability-high (MSI-H) is an established biomarker of response to immune checkpoint inhibitors, though it is rarely observed in pancreatic ductal adenocarcinoma (PDAC). Even less common is the emergen... ...
